Ad
related to: moderna third dose
Search results
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
Investor's Business Daily· 5 days agoModerna Stock: A Second Product Launch Moderna tested its RSV vaccine in 35,541 adults. After a...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 5 days agoThe shot prompts an immune response against a patient's own tumor cells. The cancer vaccine reduced...
The U.S. Is Close To Bankrolling Moderna's Bird Flu Vaccine As Third Dairy Worker Tests Positive
Investor's Business Daily· 6 days agoHowever, a third dairy worker tested positive Thursday for the virus. All three have occurred since...
US nears deal to fund Moderna’s bird flu vaccine trial, FT reports
KFGO· 6 days ago(Reuters) - The U.S. government is nearing an agreement to fund a late-stage trial of Moderna's mRNA...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks via Yahoo Finance· 2 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the...
Scientists are testing mRNA vaccines to protect cows and people against bird flu
Associated Press via Yahoo News· 5 days agoThe bird flu outbreak in U.S. dairy cows is prompting development of new, next-generation mRNA...
Moderna rises on FT report about bird flu vaccines By Investing.com
Investing.com· 6 days agoShares of Moderna (NASDAQ:MRNA) are up 2.8% premarket Thursday after a report from The Financial...
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 2 days agoModerna says the same mRNA technology that fueled its COVID-19 vaccine is proving effective in fighting melanoma. The company presented the latest...
US Nears Deal To Fund Moderna mRNA Bird Flu Shot Trial, Report Says
Forbes· 6 days agoThe U.S. government is closing in on a deal to fund a late-stage trial for an mRNA pandemic bird flu...
Moderna's RSV Vaccine Approved by FDA
Medscape· 2 days agoFor the first time, an mRNA vaccine has been approved for an indication other than COVID-19. The vaccine will join a couple other immunizations currently on the market for respiratory syncytial virus.
